Peter H. Watson
Impact in
- Cancer Research top 0.1%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- S100 Proteins and Annexins 19
- Oncology 61
- HER2/EGFR in Cancer Research 19
- Co-authors
- Leigh C. Murphy (75 shared papers)Etienne Leygue (43 shared papers)H. Lynch (1 shared paper)Hans F. A. Vasen (1 shared paper)Jukka‐Pekka Mecklin (1 shared paper)Adrian L. Harris (11 shared papers)Katy Milne (16 shared papers)Helmut Dotzlaw (23 shared papers)
- Journals
- Biopreservation and Biobanking (48 papers)Breast Cancer Research and Treatment (11 papers)Clinical Cancer Research (9 papers)Breast Cancer Research (8 papers)British Journal of Cancer (8 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Peter H. Watson
254 papers receiving 19.2k citations
Peter H. Watson's Hit Papers
Peers
Comparison fields: 5 of 192
- Cancer Research 4.1k
- Oncology 5.6k
- Pathology and Forensic Medicine 2.2k
- Immunology 2.4k
- Molecular Biology 8.1k
Countries citing papers authored by Peter H. Watson
This map shows the geographic impact of Peter H. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter H. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter H. Watson more than expected).
Fields of papers citing papers by Peter H. Watson
This network shows the impact of papers produced by Peter H. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter H. Watson. The network helps show where Peter H. Watson may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter H. Watson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 259 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC☆ Hit paper breakdown → | 1999 | 1824 |
| 2 | Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma Hit paper breakdown → | 2011 | 1512 |
| 3 | Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Hit paper breakdown → | 2000 | 1089 |
| 4 | HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Hit paper breakdown → | 2001 | 609 |
| 5 | CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer Hit paper breakdown → | 2012 | 420 |
| 6 | 1995 | 376 | |
| 7 | 2001 | 364 | |
| 8 | 2002 | 343 | |
| 9 | 2009 | 342 | |
| 10 | Tumor-Infiltrating Lymphocytes Expressing the Tissue Resident Memory Marker CD103 Are Associated with Increased Survival in High-Grade Serous Ovarian Cancer Hit paper breakdown → | 2013 | 341 |
| 11 | 2005 | 301 | |
| 12 | 2011 | 285 | |
| 13 | 2013 | 262 | |
| 14 | 2011 | 253 | |
| 15 | 2011 | 248 | |
| 16 | Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. | 1998 | 231 |
| 17 | 2003 | 213 | |
| 18 | Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. | 2003 | 209 |
| 19 | 2001 | 208 | |
| 20 | Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. | 2001 | 208 |
About Peter H. Watson
Peter H. Watson is a scholar working on Molecular Biology, Oncology, Cancer Research, Public Health, Environmental and Occupational Health and Genetics, having authored 259 papers that have together received 19.5k indexed citations. Recurring topics across this work include Ethics in Clinical Research (49 papers), Estrogen and related hormone effects (42 papers), Biomedical Ethics and Regulation (26 papers), Health Systems, Economic Evaluations, Quality of Life (22 papers), Cancer Genomics and Diagnostics (21 papers), HER2/EGFR in Cancer Research (19 papers), S100 Proteins and Annexins (19 papers) and Breast Cancer Treatment Studies (15 papers). The work is most often cited by research in Cancer Research (4.1k citations), Oncology (5.6k citations), Pathology and Forensic Medicine (2.2k citations), Immunology (2.4k citations) and Molecular Biology (8.1k citations). Peter H. Watson has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Leigh C. Murphy, Etienne Leygue, H. Lynch, Hans F. A. Vasen, Jukka‐Pekka Mecklin, Adrian L. Harris, Katy Milne, Helmut Dotzlaw, Peter J. Ratcliffe and Brad H. Nelson. Their work appears in journals such as Biopreservation and Biobanking, Breast Cancer Research and Treatment, Clinical Cancer Research, Breast Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.